Clinical and Translational Science Institute

Active

Phase II trial of androgen deprivation therapy (ADT) and pembrolizumab for advanced stage androgenreceptor-positive salivary gland carcinoma: Big Ten Cancer Research Consortium BTCRC-HN17-111

Patel, M. R.

BIG TEN CANCER RESEARCH CONSORTIUM, MERCK, SHARP & DOHME LLC

9/17/18 → 9/30/25

Project: Research project

A Phase 2, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of KD025 in Subjects with Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy

Arora, M.

KADMON CORPORATION, LLC

9/11/18 → 9/30/24

Project: Research project

A Phase I, Open-Label, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of SNDX-6352 in Subjects with Active Chronic Graft Versus Host Disease who have Received at least 2 Lines of Prior Therapy, i

Holtan, S. G. & Arora, M.

SYNDAX PHARMACEUTICALS

9/1/18 → 2/28/24

Project: Research project

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate plus Prednisonewith or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer

Jha, G. & Rao, A.

ELI LILLY AND COMPANY

9/1/18 → 6/15/26

Project: Research project

A Randomized, Double-Blind, Phase 3 Comparison of Platinum-Based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-Based Therapy as First-Line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer

Teoh, D. G.

TESARO, INC.

9/1/18 → 6/26/26

Project: Research project

A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients with Recurrent Small Cell LungCancer: Big Ten Cancer Research Consortium BTCRC-LUN17-127

Fujioka, N.

BIG TEN CANCER RESEARCH CONSORTIUM, BRISTOL-MYERS SQUIBB PHARM RES

8/30/18 → 8/30/24

Project: Research project

Phase I/II Study of Nivolumab in Combination with Ruxolitinib in Relapsed or Refractory Hodgkin's LymphomaHodgkin???s Lymphoma

Bachanova, V.

BRISTOL-MYERS SQUIBB COMPANY

8/16/18 → 8/15/28

Project: Research project

HM2018-13 :A GLOBAL RANDOMIZED MULTICENTER PHASE 3 TRIAL TO COMPARE THE EFFICACY ANDSAFETY OF JCAR017 TO STANDARD OF CARE IN ADULT SUBJECTS WITH HIGH-RISK, TRANSPLANTELIGIBLE RELAPSED OR REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMAS(TRANSFORM)

Bachanova, V.

CELGENE CORPORATION

7/25/18 → 7/31/24

Project: Research project

Adenosine Contrast CorrELations in Evaluating RevAscularizaTION

Raveendran, G.

DUKE UNIVERSITY MEDICAL CENTER

7/1/18 → 12/31/23

Project: Research project

Hemodynamic-GUIDEd Management of Heart Failure (GUIDE-HF)

Alexy, T.

ABBOTT LABORATORIES

7/1/18 → 12/31/23

Project: Research project

PANOVA-3: Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields, 150kHz)concomitant with gemcitabine and nab-paclitaxel for front-line treatment of locally-advanced pancreaticadenocarcinoma

Lou, E.

NOVOCURE INC.

5/1/18 → 5/31/24

Project: Research project

Assessment of the CARILLON® Mitral Contour System® in Treating Functional Mitral Regurgitation Associated with Heart Failure - The CARILLON Trial

Helmer, G. A.

CARDIAC DIMENSIONS, INC.

4/1/18 → 12/31/27

Project: Research project

A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

Antonarakis, E., Rao, A. & Ryan, C.

ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY, JANSSEN PHARMACEUTICALS, INC.

4/1/18 → 4/30/26

Project: Research project

Institutional Career Development Core

Ingbar, D. H.

NIH NAT'L CTR FOR ADVANCING TRAN SCIENCE

3/30/18 → 2/29/24

Project: Research project

Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients withAsYmptomatic Severe Aortic Stenosis: EARLY TAVR trial

Helmer, G. A.

EDWARDS LIFESCIENCES LLC

3/1/18 → 2/28/29

Project: Research project

A Phase I Study of Neihulizumab (AbGn-168H) in Patients

Holtan, S. G.

ABGENOMICS INTERNATIONAL INC

3/1/18 → 3/1/24

Project: Research project

Phase II Study of Consolidation Immunotherapy with Nivolumab and Ipilimumab or Nivolumab alonefollowing Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer(NSCLC)

Fujioka, N.

BIG TEN CANCER RESEARCH CONSORTIUM, BRISTOL-MYERS SQUIBB PHARM RES

1/1/18 → 1/31/24

Project: Research project

A phase 1b dose-escalation and dose-expansion study of e

Antonarakis, E., Gupta, S. & Rao, A.

SEAGEN INC

12/1/17 → 12/31/26

Project: Research project

Single Arm Phase II Study of Ipilimumab and Nivolumab as

Domingo-Musibay, E. & Holtan, S. G.

BIG TEN CANCER RESEARCH CONSORTIUM, BRISTOL-MYERS SQUIBB COMPANY

12/1/17 → 12/31/23

Project: Research project

A Phase II Study of FOLFOX combined with Nab-Paclitaxel (FOLFOX-A) in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma

Lou, E.

BIG TEN CANCER RESEARCH CONSORTIUM, CELGENE CORPORATION

12/1/17 → 11/30/24

Project: Research project

Long-term Safety Follow-up of Subjects With Giant Cell T

Skubitz, K.

AMGEN INC

11/1/17 → 4/30/24

Project: Research project

QUILT-3.055: A Phase IIb, Single-Arm, Open-Label Study o

Patel, M. R.

ALTOR BIOSCIENCE LLC

10/1/17 → 1/31/25

Project: Research project

A phase III multicenter randomized study of atezolizumab

Geller, M. A.

GENENTECH, INC.

6/1/17 → 3/31/25

Project: Research project

CD16/IL-15/CD33 (161533) Tri specific Killer Engagers (TriKEs) for the Treatment of High Risk Myelodysplastic Syndromes, Refractory/Relapsed Acute Myeloid Leukemia and Advanced Systemic Mastocytosis

Juckett, M. B. & Warlick, E. D.

GT BIOPHARMA, INC

6/1/17 → 1/31/24

Project: Research project

Phase I Study of Nivolumab in Combination with Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma: BTCRC-HEM15-027

Bachanova, V.

BIG TEN CANCER RESEARCH CONSORTIUM

5/1/17 → 5/30/24

Project: Research project

Phase II Trial of Neoadjuvant Nivolumab with Cisplatin a

Konety, B. R. & Gupta, S.

BRISTOL-MYERS SQUIBB COMPANY

5/1/17 → 11/12/27

Project: Research project

A Phase 2, Multicenter Study to Assess the Safety and Ef

Domingo-Musibay, E.

IOVANCE BIOTHERAPEUTICS

5/1/17 → 12/31/24

Project: Research project

A Multi-Center Randomized Double Blind Placebo-Controlle

Warlick, E. D. & Ustun, C.

NATIONAL MARROW DONOR PROGRAM, ASTELLAS PHARMA US, INC

5/1/17 → 7/31/24

Project: Research project

Proposal Title: A phase 1, open-label, dose-escalation s

Beckwith, H. C.

SEAGEN INC

2/1/17 → 12/31/25

Project: Research project

Clinical Study of the BioVentrix Revivent TC System for

Alexy, T. & Missov, E.

BIOVENTRIX, INC.

1/30/17 → 1/30/24

Project: Research project

A Randomized Phase II/III study of the combination of Ce

Geller, M. A.

NRG ONCOLOGY FOUNDATION, INC.

1/1/17 → 2/28/25

Project: Research project

An open label, phase Ib, dose-escalation study evaluatin

Yee, D.

BOEHRINGER-INGELHEIM PHARMACEUTICALS

1/1/17 → 3/31/26

Project: Research project

A Phase III study comparing single-agent olaparib or the

Geller, M. A.

NRG ONCOLOGY FOUNDATION, INC.

10/1/16 → 2/28/25

Project: Research project

A Phase 3 Trial of ADXS11-001 (NSC #752718) Administered

Erickson, B. K.

ADVAXIS, INC

9/1/16 → 3/31/24

Project: Research project

A Prospective, Randomized, Controlled, Multi-Center Stud

Helmer, G. A.

EDWARDS LIFESCIENCES LLC

8/1/16 → 8/31/29

Project: Research project

A Single Arm Phase II Study of Palbociclib in Combinatio

Blaes, A. H.

HOOSIER CANCER RESEARCH NETWORK, INC

6/1/16 → 6/1/24

Project: Research project

Molecular Analysis for Therapy Choice (MATCH)

Lou, E. & Peterson, B. A.

BRIGHAM AND WOMEN'S HOSPITAL, NIH NATIONAL CANCER INSTITUTE (NCI)

4/1/16 → 12/31/27

Project: Research project

A Phase II Clinical Trial to Study the Efficacy and Safe

Zabell, J. R., Gupta, S. & Konety, B. R.

MERCK

3/1/16 → 8/31/30

Project: Research project

Coronary Interventions in High Risk Patient Using a Nove

Raveendran, G.

THORATEC INC

12/1/15 → 12/31/25

Project: Research project

A Phase III Randomized Trial Comparing Androgen Deprivat

Ryan, C. & Gupta, S.

BRIGHAM AND WOMEN'S HOSPITAL, NIH NATIONAL CANCER INSTITUTE (NCI)

7/30/15 → 12/31/27

Project: Research project

A phase 1/2 study of ALT-803 in patients with relapse/re

Bachanova, V.

ALTOR BIOSCIENCE LLC

6/1/15 → 12/30/23

Project: Research project

MT2015-12 : Phase 3 Randomized, Double-Blind, Placebo Co

Bachanova, V. & Lazaryan, A.

CELGENE CORPORATION

3/31/15 → 12/31/23

Project: Research project

Phase III Study Evaluating Palbociclib (PD-0332991), a C

Beckwith, H. C.

NAT'L SURGICAL ADJ BREAST & BOWEL PROJ., PFIZER, INC.

3/1/15 → 5/1/24

Project: Research project

Finished

Imaging of Osteonecrosis of the Femoral Head

Alsaker, B.

12/1/21 → 2/1/22

Project: Research project

Moving Human Papillomavirus (HPV) Self-Sampling into Primary Care Clinics: A Pre-Implementation Study to Address Cervical Cancer Screening Inequities in Minnesota

Xiong, S.

9/1/20 → 8/1/21

Project: Internal Grant

An observational retrospective cohort study of systemic therapies for relapsed or refractory diffuse large B cell lymphoma (R/R DLBCL), to compare outcomes to those from Tafasitamab + Lenalidomide in the L-MIND study

Bachanova, V.

MORPHOSYS AG

6/30/20 → 4/28/21

Project: Research project

Multi-center cross-sectional epidemiological study to characterize the prevalence and distribution of lipoprotein(a) levels among patients with established cardiovascular disease

Duprez, D.

NOVARTIS PHARMACEUTICALS CORPORATION

4/1/20 → 8/30/22

Project: Research project

FT516-102:APhase I, Open-Label, Multicenter Study of FT516 in Combination with Monoclonal Antibodies in Subjectswith Advanced Solid Tumors

Patel, M. R.

FATE THERAPEUTICS, INC.

2/20/20 → 3/1/23

Project: Research project

A Phase 2, Multi-Center, Open-Label Study to Evaluate Long-term Safety and Efficacy of CXA-10 in Subjects with Pulmonary Arterial Hypertension on Stable Background Therapy: Extension to Study CXA-10-301 (Complexa CXA-10-2302 - PRIMEx Open Label Extension

Prins, K. W.

COMPLEXA INC

2/1/20 → 2/28/23

Project: Research project

CB8025-21845: A Phase 2, Randomized, Double Blind, Placebo Controlled, Multiple CenterStudy To Evaluate The Safety, Tolerability, And Efficacy Of Seladelpar AdministeredFor 24 Weeks In Adult Subjects With Primary Sclerosing Cholangitis

Lake, J. R.

CYMABAY THERAPEUTICS, INC

1/29/20 → 7/30/20

Project: Research project

Clinical and Translational Science Institute

Projects

Search results